Aurélie Chauffour

Centre National de la Recherche Scientifique FR

0000-0002-8846-5069

Publications

1,744

Citations

H-Index

i10-Index

0.88

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Synergistic Activity of R207910 Combined with Pyrazinamide against Murine Tuberculosis OA

Michella Ibrahim, Koen Andries, Nacer Lounis, Aurélie Chauffour, C. Truffot-Pernot +2 more

Antimicrobial Agents and Chemotherapy 2006

179

Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15 OA

Emmanuelle Cambau, Paul Saunderson, Masao Matsuoka, Stewart T. Cole, M. Kai +95 more

Clinical Microbiology and Infection 2018

167

Genetic Basis for Natural and Acquired Resistance to the Diarylquinoline R207910 in Mycobacteria OA

S. Petrella, Emmanuelle Cambau, Aurélie Chauffour, Koen Andries, Vincent Jarlier +1 more

Antimicrobial Agents and Chemotherapy 2006

145

Combinations of R207910 with Drugs Used To Treat Multidrug-Resistant Tuberculosis Have the Potential To Shorten Treatment Duration OA

Nacer Lounis, Nicolas Véziris, Aurélie Chauffour, C. Truffot-Pernot, Koen Andries +1 more

Antimicrobial Agents and Chemotherapy 2006

145

New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring Structure OA

Elena Segala, Wladimir Sougakoff, Aurélie Chauffour, Vincent Jarlier, S. Petrella

Antimicrobial Agents and Chemotherapy 2012

119

Publications

50 total

Alpibectir–Ethionamide combination (AlpE) for the treatment of tuberculosis

Zainab Edoo, C. Grosse, T. Maitre, Rosangela Frita, A. Chauffour - Nature Communications, 2026

Cited by 0 Semantic Scholar

Does Infection Progression of Mycobacterium abscessus Depend on Sex, Age, and Mouse strain?

Maya Rima, A. Chauffour, R. Tournebize, Corentin Poignon, T. Coradin - bioRxiv, 2026

Cited by 0 Semantic Scholar

Unprecedented in vivo activity of telacebec against Mycobacterium leprae OA

A. Chauffour, E. Cambau, Kevin Pethe, Nicolas Veziris, Alexandra Aubry - PLoS Neglected Tropical Diseases, 2025

Cited by 3 Semantic Scholar

Evaluation of the role of whiB6 and kdpDE in the dominant multidrug-resistant clone Mycobacterium tuberculosis B0/W148

Isabelle Bonnet, Mickael Orgeur, F. Brossier, Fadel Sayes, Wafa Frigui - bioRxiv, 2025

Cited by 2 Semantic Scholar

Bedaquiline Activity against Leprosy

A. Fomba, F. Haidara, Mamoudou Kodio, Catherine Arama, E. Cambau - New England Journal of Medicine, 2025

Cited by 1 Semantic Scholar

The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens

Clara Aguilar-Pérez, A. Lenaerts, Cristina Villellas, Jerome Guillemont, John Dallow - Nature Communications, 2025

Cited by 1 Semantic Scholar

Levofloxacin activity at increasing doses in a murine model of fluoroquinolone-susceptible and -resistant tuberculosis

T. Maitre, A. Godmer, C. Mory, A. Chauffour, Thi Cuc Mai - Antimicrobial Agents and Chemotherapy, 2024

Cited by 3 Semantic Scholar

Minimal effective dose of oral bedaquiline and activity of a long acting formulation of bedaquiline in the murine model of leprosy Bedaquiline for the treatment of leprosy OA

A. Chauffour, N. Lounis, K. Andries, V. Jarlier, N. Veziris - bioRxiv, 2023

Cited by 0 Semantic Scholar

Minimal effective dose of bedaquiline administered orally and activity of a long acting formulation of bedaquiline in the murine model of leprosy OA

A. Chauffour, N. Lounis, Koen Andries, Vincent Jarlier, N. Veziris - PLoS Neglected Tropical Diseases, 2023

Cited by 7 Semantic Scholar

Drug resistance in leprosy: An update following 70 years of chemotherapy

Alexandra Aubry, Patrícia Sammarco Rosa, Aurélie Chauffour, M.L. Fletcher, Emmanuelle Cambau et al. - Infectious Diseases Now, 2022

Cited by 39 OpenAlex

Research Topics

Tuberculosis Research and Epidemiology (38) Mycobacterium research and diagnosis (38) Infectious Diseases and Tuberculosis (14) Leprosy Research and Treatment (14) Cancer therapeutics and mechanisms (7)

Frequent Co-Authors

Vincent Jarlier

12 joint publications

Koen Andries

5 joint publications

Nicolas Véziris

5 joint publications

Emmanuelle Cambau

5 joint publications

Nacer Lounis

3 joint publications

C. Truffot-Pernot

3 joint publications

Affiliations

Centre National de la Recherche Scientifique

FR 2026 - 2025

Johnson & Johnson (United States)

US 2006 - 2006

Janssen (Belgium)

BE 2006 - 2006

Inserm

FR 2026 - 2006

Université Paris Cité

FR 2014 - 2010

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers

Aurélie Chauffour

Publication & Citation Trends

Most Cited Works

Publications

Alpibectir–Ethionamide combination (AlpE) for the treatment of tuberculosis

Does Infection Progression of Mycobacterium abscessus Depend on Sex, Age, and Mouse strain?

Unprecedented in vivo activity of telacebec against Mycobacterium leprae OA

Evaluation of the role of whiB6 and kdpDE in the dominant multidrug-resistant clone Mycobacterium tuberculosis B0/W148

Bedaquiline Activity against Leprosy

The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens

Levofloxacin activity at increasing doses in a murine model of fluoroquinolone-susceptible and -resistant tuberculosis

Minimal effective dose of oral bedaquiline and activity of a long acting formulation of bedaquiline in the murine model of leprosy Bedaquiline for the treatment of leprosy OA

Minimal effective dose of bedaquiline administered orally and activity of a long acting formulation of bedaquiline in the murine model of leprosy OA

Drug resistance in leprosy: An update following 70 years of chemotherapy

Research Topics

Frequent Co-Authors

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back